
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
---|---|---|---|---|---|---|
09/30/2025 | Q3 | $1B | -- | -- | $1.22 | -- |
07/23/2025 | Q2 | $996.6M | -- | -- | $1.08 | -- |
04/23/2025 | Q1 | $966M | $968.3M | $0.48 | $0.95 | -$0.47 |
02/05/2025 | Q4 | $1B | $985M | $0.95 | $1.21 | -$0.26 |
10/23/2024 | Q3 | $1B | $1B | $1.06 | $1.35 | -$0.29 |
07/24/2024 | Q2 | $1B | $1B | $1.02 | $1.33 | -$0.31 |
04/24/2024 | Q1 | $1B | $1B | $0.81 | $1.14 | -$0.33 |
02/07/2024 | Q4 | $1.1B | $1.1B | $1.06 | $1.33 | -$0.27 |
10/25/2023 | Q3 | $1.1B | $1.1B | $1.23 | $1.56 | -$0.33 |
07/26/2023 | Q2 | $1.1B | $1.1B | $1.22 | $1.45 | -$0.23 |
04/26/2023 | Q1 | -- | $1.1B | $0.99 | -- | -- |
02/08/2023 | Q4 | -- | $1.2B | $1.10 | -- | -- |
10/26/2022 | Q3 | -- | $1.2B | $1.44 | -- | -- |
07/27/2022 | Q2 | -- | $1.1B | $1.41 | -- | -- |
04/27/2022 | Q1 | -- | $1.1B | $1.28 | -- | -- |
02/09/2022 | Q4 | -- | $1.1B | $1.61 | -- | -- |
10/27/2021 | Q3 | -- | $1.1B | $3.97 | -- | -- |
07/28/2021 | Q2 | -- | $974.9M | $1.19 | -- | -- |
04/28/2021 | Q1 | -- | $907M | $0.91 | -- | -- |
02/10/2021 | Q4 | -- | $900.4M | $1.04 | -- | -- |
10/28/2020 | Q3 | -- | $904.4M | $0.99 | -- | -- |
07/29/2020 | Q2 | -- | $831.9M | $0.92 | -- | -- |
04/30/2020 | Q1 | -- | $990.5M | $0.82 | -- | -- |
02/12/2020 | Q4 | -- | $516.9M | $0.74 | -- | -- |
11/04/2019 | Q3 | -- | $1B | $1.08 | -- | -- |
07/24/2019 | Q2 | -- | $972.3M | $0.81 | -- | -- |
04/24/2019 | Q1 | -- | $923.7M | $0.66 | -- | -- |
02/13/2019 | Q4 | -- | $929.7M | $0.86 | -- | -- |
10/24/2018 | Q3 | -- | $906.4M | $0.93 | -- | -- |
07/25/2018 | Q2 | -- | $878.5M | $0.63 | -- | -- |
04/25/2018 | Q1 | -- | $685.2M | $0.55 | -- | -- |
02/14/2018 | Q4 | -- | $679.1M | $1.28 | -- | -- |
10/25/2017 | Q3 | -- | $667M | $0.66 | -- | -- |
07/26/2017 | Q2 | -- | $653.3M | $0.62 | -- | -- |
04/26/2017 | Q1 | -- | $626.5M | $0.42 | -- | -- |
02/14/2017 | Q4 | -- | $620.9M | $0.45 | -- | -- |
10/27/2016 | Q3 | -- | $629.4M | $0.55 | -- | -- |
07/27/2016 | Q2 | -- | $608.1M | $0.48 | -- | -- |
04/06/2016 | Q1 | -- | $582M | $0.32 | -- | -- |
02/17/2016 | Q4 | -- | $577.5M | $0.36 | -- | -- |
10/28/2015 | Q3 | -- | $572.1M | $0.47 | -- | -- |
ASGN reported $968.3M worth of top line sales in its most recent quarter.
ASGN announced earnings per share of $0.48 which represents a miss of analyst forecast a $0.95 per share.
ASGN reported $275.4M that represents $6.26 per share over the last quarter.
ASGN's earnings are forecast to grow from $3.83 per share to $5.16 per share next year representing an increase of 15.95%.
ASGN's next earnings date is July 23, 2025.
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.